Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2014-11-18

Clinical Trial Update: 64N Nutraceutical for the Prevention of Childhood Diarrhea and Pneumonia in Low Resource Settings [NA]

View source ↗

Summary

A clinical trial update on 64N Nutraceutical for preventing diarrhea and pneumonia in children in low-resource settings; the trial status is currently unknown.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • 64N Nutraceutical

Snippet

Sponsor: H2O Health and Agriculture LLC | Conditions: Diarrhea, Pneumonia | NA | Status: UNKNOWN